Dr Awen Gallimore



Prosiectau fel Prif Ymchwiliwr
null null 1 o 3 null null

CD59 as a modulator of human T cells - Cyllidwr:Wellcome Trust (01.10.2008 - 01.08.2009)
The body's battle against cancer - Cyllidwr:Wellcome Trust (01.06.2015 - 29.02.2016)
Treating metastatic disease by manipulation of regulatory T cells - Cyllidwr:Tenovus (01.10.2013 - 30.09.2016)
Elucidating the role of regulatory T cells in colorectal cancer progression - Cyllidwr:Cancer Research Wales (01.10.2011 - 30.09.2014)
Immunospot s6 Ultra-V - Cyllidwr:Welsh Government (HCRW), - Cyllidwr:Wellcome Trust (01.07.2014 - 30.09.2014)


Prosiectau fel Cyd-Ymchwiliwr
null null 2 o 6 null null

Identifying the influence of the microbiome and metabiome on the normal and malignant murine intestinal stem cell - Cyllidwr:World Cancer Research Fund International (01.11.2013 - 03.01.2018)
Mechanisms of natural killer cell activation and evasion by Hepatitis C virus - Cyllidwr:European Society of Clinical Microbiology and Infectious Diseases (01.03.2012 - 16.06.2014)
Development of novel CD200:CD200R blockade cancer immunotherapy - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.06.2015 - 31.05.2016)
Evaluating whether autoreactive T cells promote progression of colorectal cancer - Cyllidwr:Cancer Research Wales (01.10.2014 - 30.09.2018)
The role of CCR8 in cutaneous vaccination - Cyllidwr:Medical Research Council (01.05.2014 - 30.09.2017)

Diweddarwyd y tro diwethaf ar 2020-02-08 am 04:01